Literature DB >> 18677227

Effect of viscosity on tear drainage and ocular residence time.

Heng Zhu1, Anuj Chauhan.   

Abstract

PURPOSE: An increase in residence time of dry eye medications including artificial tears will likely enhance therapeutic benefits. The drainage rates and the residence time of eye drops depend on the viscosity of the instilled fluids. However, a quantitative understanding of the dependence of drainage rates and the residence time on viscosity is lacking. The current study aims to develop a mathematical model for the drainage of Newtonian fluids and also for power-law non-Newtonian fluids of different viscosities.
METHODS: This study is an extension of our previous study on the mathematical model of tear drainage. The tear drainage model is modified to describe the drainage of Newtonian fluids with viscosities higher than the tear viscosity and power-law non-Newtonian fluids with rheological parameters obtained from fitting experimental data in literature. The drainage rate through canaliculi was derived from the modified drainage model and was incorporated into a tear mass balance to calculate the transients of total solute quantity in ocular fluids and the bioavailability of instilled drugs.
RESULTS: For Newtonian fluids, increasing the viscosity does not affect the drainage rate unless the viscosity exceeds a critical value of about 4.4 cp. The viscosity has a maximum impact on drainage rate around a value of about 100 cp. The trends are similar for shear thinning power law fluids. The transients of total solute quantity, and the residence time agrees at least qualitatively with experimental studies.
CONCLUSIONS: A mathematical model has been developed for the drainage of Newtonian fluids and power-law fluids through canaliculi. The model can quantitatively explain different experimental observations on the effect of viscosity on the residence of instilled fluids on the ocular surface. The current study is helpful for understanding the mechanism of fluid drainage from the ocular surface and for improving the design of dry eye treatments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18677227     DOI: 10.1097/OPX.0b013e3181824dc4

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  15 in total

1.  General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Authors:  Feng Deng; Veli-Pekka Ranta; Heidi Kidron; Arto Urtti
Journal:  Pharm Res       Date:  2016-07-18       Impact factor: 4.200

2.  Optimization of dexamethasone mixed nanomicellar formulation.

Authors:  Kishore Cholkar; Sudharshan Hariharan; Sriram Gunda; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-07-01       Impact factor: 3.246

3.  Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

Authors:  Kishore Cholkar; Sriram Gunda; Ravinder Earla; Dhananjay Pal; Ashim K Mitra
Journal:  AAPS PharmSciTech       Date:  2014-11-26       Impact factor: 3.246

4.  Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes.

Authors:  Seham A Elkheshen; Rania M Hathout; Engy A Abdel Azim; Marwa A Fouly; Nada M El Hoffy
Journal:  Int J Nanomedicine       Date:  2022-06-25

5.  Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy: Development, Characterization, and Pharmacodynamic Study.

Authors:  Parasuraman Mohan; Karthikeyan Kesavan
Journal:  AAPS PharmSciTech       Date:  2021-06-28       Impact factor: 3.246

6.  Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery.

Authors:  Kishore Cholkar; Brian C Gilger; Ashim K Mitra
Journal:  Transl Vis Sci Technol       Date:  2015-05-01       Impact factor: 3.283

7.  Effect of Hyaluronic Acid/Trehalose in Two Different Formulations on Signs and Symptoms in Patients with Moderate to Severe Dry Eye Disease.

Authors:  Klemens Fondi; Piotr A Wozniak; Doreen Schmidl; Ahmed M Bata; Katarzyna J Witkowska; Alina Popa-Cherecheanu; Leopold Schmetterer; Gerhard Garhöfer
Journal:  J Ophthalmol       Date:  2018-08-01       Impact factor: 1.909

8.  Kinetics of Fluorescein in Tear Film After Eye Drop Instillation in Beagle Dogs: Does Size Really Matter?

Authors:  Lionel Sebbag; Nicolette S Kirner; Rachel A Allbaugh; Alysha Reis; Jonathan P Mochel
Journal:  Front Vet Sci       Date:  2019-12-19

Review 9.  Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review.

Authors:  Teodora Irimia; Cristina-Elena Dinu-Pîrvu; Mihaela Violeta Ghica; Dumitru Lupuleasa; Daniela-Lucia Muntean; Denisa Ioana Udeanu; Lăcrămioara Popa
Journal:  Mar Drugs       Date:  2018-10-09       Impact factor: 5.118

Review 10.  The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.

Authors:  Lixiang Wang; Mikael Ben Zhou; Hui Zhang
Journal:  Ophthalmol Ther       Date:  2021-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.